(Q39017829)

https://doi.org/10.3892/mmr.2021.12279

8 September 2017

1 reference

29 December 2023

title

microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells (English)

1 reference

8 September 2017

1 reference

1 reference

1 reference

Shaoru Li

1

1 reference

8 September 2017

Yan Li

2

1 reference

8 September 2017

Zhengfang Wen

3

1 reference

8 September 2017

Fanjing Kong

4

1 reference

8 September 2017

Xinlei Guan

5

1 reference

8 September 2017

Wenhui Liu

6

1 reference

8 September 2017

publication date

6 March 2014

1 reference

Molecular Medicine Reports

8 September 2017

published in

1 reference

8 September 2017

volume

9

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

1703-1708

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

8 September 2017

cites work

Cancer statistics, 2009

1 reference

28 May 2022

Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

MicroRNAs as mediators of viral evasion of the immune system

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Matrix metalloproteinases: changing roles in tumor progression and metastasis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Gonadotropins and ovarian cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Pathogenic arterial remodeling: the good and bad of microRNAs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3892/MMR.2014.2021

Identifiers

DOI

10.3892/MMR.2014.2021

1 reference

8 September 2017

1 reference